AstraZeneca's Olaparib Pill Reduced Risk of Recurrence in Early Stage, Hard-to-Treat Breast Cancers Medicine & Technology Jun 03, 2021 A study reveals that adjuvant olaparib could help keep breast cancer at bay after initial treatment and help breast cancer patients live longer without the disease.
TECH & INNOVATION OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find 'Hallucinated' Text in Transcripts